Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence

Area of Science:

• Microbiology
• Immunology
• Biochemistry

Background:

• Staphylococcus aureus commonly produces capsular polysaccharides serotype 5 (CP5) or serotype 8 (CP8).
• Understanding differences in biological properties between CP5 and CP8 is crucial for explaining their varying roles in infection.

Purpose of the Study:

• To investigate and compare the biological properties of CP5 and CP8.
• To determine how these differences influence Staphylococcus aureus virulence in vivo.

Main Methods:

• Created isogenic Staphylococcus aureus mutants expressing CP5, CP8, or no capsule.
• Performed biochemical analyses of purified polysaccharides.
• Assessed bacterial survival and virulence in mouse models and in vitro killing assays using human neutrophils and sera.

Main Results:

• CP5 exhibited a greater degree of N-acetylation compared to CP8.
• Mice infected with the CP5 strain showed significantly higher bacteremia and preferential survival in bloodstream and kidneys.
• The CP5 strain demonstrated enhanced resistance to killing in whole mouse blood and superior survival in opsonophagocytic assays.

Conclusions:

• CP5 and CP8 possess distinct biological properties, including differences in N-acetylation.
• These variations contribute to the enhanced virulence of CP5-producing Staphylococcus aureus strains in vivo.
• CP5's resistance to host immune mechanisms, such as complement and phagocytosis, plays a key role in its pathogenicity.